IRAK3 and central nervous system cancer: Mechanistic studies have shown that promoter methylation of IRAK3 is a key epigenetic mechanism underlying its silencing, a phenomenon not only observed in hepatocellular carcinoma (62), but also reflected by increased methylation levels negatively correlated with gene expression in gliomas (63).